The Dax-1 protein is an enigmatic nuclear receptor that lacks an expected DNA binding domain, yet functions as a potent corepressor of nuclear receptors. Here we report the structure of Dax-1 bound to one of its targets, liver receptor homolog 1 (LRH-1). Unexpectedly, Dax-1 binds to LRH-1 using a new module, a repressor helix built from a family conserved sequence motif, PCFXXLP. Mutations in this repressor helix that are linked with human endocrine disorders dissociate the complex and attenuate Dax-1 function. The structure of the Dax-1:LRH-1 complex provides the molecular mechanism for the function of Dax-1 as a potent transcriptional repressor.
T he orphan nuclear receptor DAX-1/Dax-1 (dosage-sensitive sex-reversal adrenal hypoplasia congenital critical region on the X chromosome gene 1) (1) is well known for its role in human pathophysiology. Duplication of the DAX-1 gene causes phenotypic sex reversal in XY individuals (2) , and mutations in DAX-1 are responsible for adrenal hypoplasia congenita, an inherited disorder of adrenal gland development (3) . During embryogenesis, Dax-1 functions to direct cell differentiation in testes and adrenal tissues (1) . In adult physiology, Dax-1 acts as a global repressor of many nuclear receptors, including SF-1, Nur77, ERR␥, ER, AR, PR, and LRH-1 (4-13). Dax-1 also is indispensable to maintaining the pluripotent state of embryonic stem cells (14, 15) .
There is a little information on either the structure or regulatory mechanisms of Dax-1. Dax-1 belongs to a unique family of nuclear receptors (NR0B1) that lack the essential DNA binding domain. Instead, the human Dax-1 N terminus consists of three sequence repeats that include the LXXL/ML motif (''LXXL/ML boxes'' 1-3) (16) . This unique N-terminal extension is thought to play a role in subcellular distribution and nuclear localization of Dax-1 (17) . No homologues for the N-terminal region of Dax-1 are known, but its C-terminal domain is a clear homologue of the nuclear receptor ligandbinding domain (LBD) (1) . To date, no hormone for Dax-1 has been identified, and the mechanism of its function as corepressor remains under debate (4, 5, 7-9, 12, 18-20) . The elucidation of Dax-1 mechanisms has been frustrated by a lack of highresolution structural information. Here we report the first structure of Dax-1 bound to its physiological target, nuclear receptor liver receptor homolog 1 (LRH-1; NR5A2).
LRH-1 was first discovered in the liver and intestine, where it regulates genes controlling bile acid synthesis and cholesterol homeostasis (21) (22) (23) (24) . Recently, LRH-1 was found in human steroidogenic tissues and was shown to activate transcription of genes encoding steroidogenic enzymes (25) . In particular, regulation of the CYP19A gene encoding aromatase, which converts androgens to estrogens, gives LRH-1 a pivotal role in estrogen signaling (25) (26) (27) (28) . Similar to Dax-1, LRH-1 is indispensable to maintaining the pluripotent state of embryonic stem cells (29) .
Unlike other nuclear receptors that function as homodimers or heterodimers, LRH-1 binds DNA with high affinity as a monomer (30, 31) . In contrast to hormone-controlled nuclear receptors, physiological ligands for LRH- 1 have not yet been identified, consistent with the fact that NR5A receptors activate reporter gene transcription in the absence of exogenously added ligands (32) . Structural studies of LRH-1 (33-37) have revealed its LBD in the active conformation and suggested phosphatidylinositols as potential candidate hormones for this receptor (34) ; however, whether these ligands stabilize the LBD or function as regulating hormones remains to be determined. The hinge region preceding the LRH-1 LBD provides additional sites for receptor regulation through posttranslational modification (38) .
Recent studies have found that the two targets of our work, LRH-1 and Dax-1, are coexpressed in the ovary, where they regulate production of steroid hormones (39) (40) (41) (42) . These findings show that Dax-1 is a key physiological regulator of LRH-1 transcriptional activity and LRH-1-mediated steroidogenesis. The present work provides the first structural and functional analysis of a regulatory Dax-1:LRH-1 assembly and suggests a mechanism for Dax-1 function as a potent transcriptional repressor.
Results

Preparation and Characterization of the (Dax-1)2:LRH-1 Heterotrimer.
To evaluate whether Dax-1 can bind to LRH-1 in vitro, we performed the standard GST pull-down assay using bacterially expressed and purified GST-LRH-1 LBD fusion protein and in vitro transcribed and translated 35 S-labeled full-length Dax-1. The results of this experiment show that Dax-1 interacted with LRH-1 LBD in the absence of any added hormones or coregulatory proteins. Moreover, under the same conditions, the observed Dax-1-LRH-1 binding exceeded the analogous interactions with nuclear receptor SF-1, another functional target of Dax-1 (supporting information (SI) Fig. S1 ).
Because multiple regions of Dax-1 have been reported to bind nuclear receptors (4, 5, (7) (8) (9) 12) , we assessed the binding of five different fragments of Dax-1 to LRH-1 LBD: its N-terminal region (aa 1-208), the LBD (aa 205-472), the LBD with preceding LXXL/ML repeats (aa 138-472 and 70-472), and full-length Dax-1 (aa 1-472). Of these fragments, only the putative Dax-1 LBD produced a stable complex with LRH-1 (Fig. S2) . Further biochemical analyses of the purified Dax-1:LRH-1 complex showed that the assembly is a heterotrimer with a Dax-1:LRH-1 ratio of 2:1 ( Fig. S3 A and B) . Consistent with these data, analytical ultracentrifugation revealed the presence of a single protein species with a molecular mass of Ϸ90 kDa, which agrees with the calculated molecular mass of the (Dax-1) 2 :LRH-1 heterotrimer.
We characterized the binding affinity of Dax-1 LBD for LRH-1. Direct binding experiments using surface plasmon resonance showed that these proteins interact with high affinity (K d ϭ 0.9 ϩ/-0.1 M; Fig. S3C ), comparable to the reported affinities of other nuclear receptors for their functional regulators (34, (43) (44) (45) . Notably, the binding affinity of Dax-1 LBD for LRH-1 exceeds the affinity of Dax-1 peptides containing the N-terminal LXXL/ML motifs for LRH-1 (34) by more than 30-fold. This comparative analysis suggests that the observed interactions between Dax-1 and LRH-1 LBDs are functionally relevant. The purified Dax:LRH-1 complex was crystallized, and its three-dimensional structure was solved using the molecular replacement method. Consistent with the biochemical data, the asymmetric unit of the crystalline complex revealed one (Dax-1) 2 :LRH-1 heterotrimer (Fig. 1) . The structure of the complex was refined to 3.0 Å with R free /R values of 26.1/23.4 ( Fig. S4 ) and included amino acid residues 318-559 for LRH-1 LBD and 250-315, 353-472 and 250-312, 353-472 for the first and second molecules of Dax-1, respectively. The N-terminal region (aa 205-249) of both Dax-1 molecules was not visible on the electron density maps of the complex and not included in the structure. Details of the structure determination and refinement are summarized in Table S1 .
Dax-1 Dimerization and Its Determinants. The trimeric structure of the complex suggested that Dax-1 may form a homodimer. To probe the existence of a Dax-1 dimer, we coexpressed three pairs of Dax-1 deletion mutants tagged with either His 6 or S tags ( Fig.  2A) . Analysis of purified His 6 -tagged proteins revealed that the Dax-1 fragment 205-472 used in our structural analysis is a dimer in solution, as determined by its association with the S-tagged Dax-1 (Fig. 2B ). This finding was confirmed by size exclusion chromatography revealing the presence of a single protein species with molecular mass of Ϸ60 kDa in a purified Dax-1 205-472 protein sample (Fig. S5A) . This value agrees with the calculated molecular mass for the Dax-1 dimer. In contrast, a shorter fragment of Dax-1 corresponding to the visible Dax-1 LBD (aa 245-472) is a monomer, as determined by Western blot and size exclusion chromatography analyses (Figs. 2 and S5B) . We conclude that 40 residues (aa 205-245) N-terminal to the visible Dax-1 LBD are sufficient to form and maintain a stable Dax-1 homodimer in vitro. Therefore, the presence of the second Dax-1 LBD in the (Dax-1) 2 :LRH-1 heterotrimer is a direct consequence of the dimeric state of Dax-1 (Fig. S5C ). (46, 47) . With the exception of these two regions, the rest of the Dax-1 LBD folds into a well-defined, compact structure.
Remarkably, the ligand-binding pocket, which usually forms the hydrophobic core of nuclear receptor LBDs, is absent in Dax-1. Three structural elements of Dax-1-helices H11, H5, and the short ␤-strand following H5-reroute in a short cut to eliminate the pocket ( Fig. 3 A and B) . The resulting volume of the ligand-binding cavity is about 80 Å 3 (compared with 830 Å Functional Conformations of Dax-1 and LRH-1 LBDs. Similar to the structure of mLRH-1 alone (33), the mLRH-1 LBD in the trimer is without hormone and in an active conformation, as defined by the position of helix H12 (Fig. 1) . Furthermore, superimposition of the complexed LRH-1 with free LRH-1 (33) shows nearly identical LBD structures (with a rmsd for 242 C␣ atoms of 0.9 Å), demonstrating that LRH-1 does not assume a different conformation when inactivated by Dax-1. The trimer also can form with mLRH-1 mutant A268W, a functional receptor with an occluded ligand-binding cavity (33) , indicating that Dax-1 does not require an LRH-1 hormone for binding. Both Dax-1 molecules in the complex are found in an identical conformation (with an rmsd for 183 C␣ of 0.7 Å), which differs from that of the LRH-1 LBD. Each is characterized by docking of helix H12 into its own coactivator-binding groove (Figs. 1 and  3A) . In other nuclear receptors, this groove is known to bind the nuclear receptor coactivator boxes containing the LXXLL motif (43, 48, 49) . In Dax-1, the conserved M464, M467, and L468 from H12 (MXXML; Fig. 3A ) mimic the Leu residues from the LXXLL motif. The docked position of H12 in Dax-1 is consistent with its function as a repressor that does not need to bind coactivator.
Architecture of the (Dax-1)2:LRH-1 Heterotrimer. The two bound molecules of Dax-1 are curiously positioned in the complex (Fig.  1) . The first Dax-1 LBD is docked into the coactivator groove of LRH-1, forming a large binding interface of Ϸ1350 Å 3 . Surprisingly, the core structural element used by Dax-1 for binding to LRH-1 is a compact loop connecting helices H3 and H4. This loop forms a short helix, termed a ''repression helix'' (RH) (Fig.  4A and B) , bordered by two conserved Pro residues, P275 and P281, which introduce two turns into the Dax-1 polypeptide chain. The helical conformation of the RH site is very stable and is supported by multiple intramolecular contacts (Fig. 4B ). This property is rather uncommon for accessible surface loops, which often are flexible. Another unusual property of the RH is the presence of a cluster of solvent-exposed hydrophobic residues (C276, I279, and L280; Fig. 4B ), which suggests that this site might have evolved for intermolecular protein interactions.
Superimposition of the (Dax-1) 2 :LRH-1 complex with the structures of hLRH-1 bound to the GRIP-1 peptide (34, 37) shows that the position and conformation of the RH in the complex are similar to those of the docked regulatory peptide. However, the RH site of mDax-1 does not have the LXXLL motif present in nuclear receptor coactivators. Instead, the RH site includes a sequence motif, 275-PCFXXLP-281, conserved among all members of the NR0B1 subfamily. Thus, the exposed hydrophobic residues C276, I279, and L280 from the Dax-1 repressor helix (Fig. 4B ) substitute for the three Leu residues from the LXXLL motif of the coactivators. The N-terminal region of Dax-1 helix H9 with preceding loop L8-9 ( Fig. 4A ) extends this interface with LRH-1 to Ϸ1350 Å 2 . The second Dax-1 is positioned in the vicinity of the first Dax-1 LBD, just outside the ligand-binding pocket of LRH-1 (Fig. 1) . Curiously, for its interaction with LRH-1, the second Dax-1 uses the same site, consisting of the RH and the N-terminal part of helix H9 (Fig. 4C) . The second Dax-1-LRH-1 interface includes the N-and C-terminal parts of LRH-1 helices H7 and H11, respectively, and is less extensive (Ϸ700 Å 2 ). Interestingly, the second Dax-1 LBD places the side chain of semiconserved Q397 in loop L8-9 at a distance of direct contact with residues at the mouth of the LRH-1 pocket. In LRH-1 from all species except rodents, this is the coordination site of the phosphate group of the bound phospholipid (Fig. S6) (34) . Thus, a bound LRH-1 ligand might influence the second Dax-1 in vivo. We observe a weak binding interface (Ϸ200 Å 2 ; Fig. 1 ) between the visible structures of Dax-1 LBDs in the heterotrimer, formed between residues positioned on the exposed faces of helix H9 of the two Dax-1 LBDs. This observation is consistent with the dimeric state of Dax-1 (Fig. 2) .
Mutational Analysis of the Dax-1-LRH-1 Interfaces. To date, more than 30 human Dax-1 missense mutations have been associated with adrenal disease (3). All mutations affect evolutionarily conserved residues positioned within the visible structure of Dax-1, suggesting that this structure corresponds to a critical functional domain. Most mutations affect buried Dax-1 residues and are predicted to destabilize the structural core of the LBD (50); however, one described mutation in hDax-1 affects a solvent-exposed hydrophobic residue (L278P in hDax-1 (3); L280P in mDax-1). Strikingly, L280 in mDax-1 is one of the conserved residues involved in the binding of Dax-1 to LRH-1 (Fig. 4B) . Substitution of L278 for Pro in hDax-1 likely would distort the helical conformation of the RH site, thereby weakening the binding interactions of Dax-1 and LRH-1. Consistent with this prediction, equivalent mutation L280P in mDax-1 resulted in diminished repression of LRH-1 by Dax-1 (Fig. 5A) . Mutating the adjacent hydrophobic I279 to negatively charged Asp eliminated the binding of Dax-1 to LRH-1 (Fig. S7) and produced a variant that no longer overpowered the coactivator (I279D in Fig. 5B ). Consistent with these results, double-mutant I279A/L280A (Fig. 5C ) attenuated the ability of Dax-1 to act as a potent corepressor of LRH-1 in cellular reporter assays. Taken together with structural data, these findings confirm the functional importance of the discovered RH and its conserved motif PCFXXLP for regulatory interactions of Dax-1 with LRH-1.
Complementary to the described mutations in Dax-1 RH site, LRH-1 mutations R380E and E553R in the primary AF-2 site eliminated Dax-1 binding to the receptor (Fig. S7) . In contrast to these AF-2 mutants, mutations at the secondary site of LRH-1 (Y538D, V541D, and Y538D/V541D; Fig. 4C ) exhibited no effect on Dax-1 binding (Fig. S7) . These results suggest that binding of the second Dax-1 to LRH-1 is mediated by the first Dax-1 docked into the AF-2 groove, likely through direct Dax-1-Dax-1 interactions that we see in part in the crystal structure. These data also are consistent with the hypothesis that Dax-1 binds to LRH-1 as a homodimer, with determining interactions at the primary AF-2 binding site. Although neither of the secondary site LRH-1 mutants produced noticeable effects on the complex formation in in vitro binding experiments, these mutants did attenuate the inhibitory function of Dax-1 in cell-based transcription assays (Fig. 5C ). An effect of these mutants was apparent when they were paired with the RH site mutant I279A/L280A, suggesting that the presence of the second Dax-1 in the complex contributes to the repressor efficiency.
Discussion
Mechanism of Transcriptional Inhibition by Dax-1. The data described in this work demonstrate that the Dax-1 LBD interacts directly with the LBD of LRH-1. Our finding that Dax-1 binds in the coactivator groove of LRH-1 is consistent with previous data showing that repression by Dax-1 could be through competitive inhibition (9) . A novel twist that our analysis introduces to this hypothesis is that the repression site is located in the Dax-1 LBD and contains the subfamily conserved sequence motif PCFXXLP (Fig. 4B) . The observed novel mode of interaction does not contradict the previous assignment for the N-terminal repeats as the region responsible for nuclear localization of Dax-1 (17) . Furthermore, the observed docking of Dax-1 LBD into the coactivator groove of LRH-1 is consistent with the recently demonstrated mode of repression of nuclear receptors Nur77 and ERR␥ by Dax-1, for which Dax-1 LBD was shown to be sufficient (7, 8) .
Our work suggests two reasons why Dax-1 functions as an efficient transcriptional inhibitor that can overpower coactivators. First, the binding interactions of Dax-1 at the AF-2 site are more extensive than those of a coactivator with a single LXXLL motif. The repression site of Dax-1 is expanded by residues presented by the well-ordered helix H9. Second, the RH site of Dax-1 is well structured and stabilized through extensive intramolecular interactions. The stability of the RH site contrasts with the dynamic nature of LXXLL motifs of nuclear receptor coactivators that are followed by flexible loops (43) , which require prestructuring for binding to nuclear receptors. We conclude that the increased interaction surface and the preordered state of the RH site underlie the efficiency of Dax-1 as a transcriptional repressor.
Dimerization of Dax-1 and Possible Functional Role of the Dax-1
Dimer. Dax-1 binds to primary and secondary sites on LRH-1. What are these sites' contributions to the trimer assembly? As discussed earlier, LRH-1 mutations in the primary AF-2 site block formation of the complex. In contrast, LRH-1 mutants with altered secondary sites behave similarly to wild-type protein. In the context of the structure, our data indicate that Dax-1 binds LRH-1 as a dimer with determining interactions at the primary AF-2 site.
What is the structure of the Dax-1 dimer? Although our group and others (51) have observed formation of Dax-1 dimers, the (Dax-1) 2 :LRH-1 structure does not reveal an obvious configuration for the Dax-1 homodimer. A previously proposed model suggests that Dax-1 molecules might dimerize through docking of the N-terminal LXXLL motifs into the coactivator grooves of their respective partners (51). Our results argue against this model, because the structure of Dax-1 reveals occupation of the AF-2 site by helix H12. Our findings also demonstrate that Dax-1 can dimerize in the absence of the LXXLL motifs, and that the presence of 40 residues preceding helix H3 is sufficient for Dax-1 dimerization. The dimerization domain of Dax-1 is not seen in the (Dax-1) 2 :LRH-1 trimer, likely because of its flexible linkage to the visible Dax-1 LBDs.
In this work, we show Dax-1 to be a dimeric repressor with one repression site present on each of the two LBDs. Fig. S8 ). In addition, the flexible association between the two Dax-1 molecules might facilitate the binding of different nuclear receptors with variable molecular surfaces. The weakly ordered contact relating the two Dax-1 LBDs in the trimer may be a functional feature that allows the pair to adjust and perform a ''claw-like'' clasping, to accommodate different nuclear receptor LBDs. We also note that the placement of the second Dax-1 at the entrance to the LRH-1 ligand-binding pocket makes the second Dax-1 LBD a candidate to serve as a ''sensor'' of the receptor's ligand state. An alternative possibility is that the second Dax-1 LBD might simply provide an additional binding interface and link the regulatory assembly to other components of the transcriptional machinery. The dimerization of Dax-1 in vivo might depend on its concentration in cells, be controlled by specific co-regulatory proteins, or be triggered by specific signaling events; therefore, both monomeric and dimeric forms of Dax-1 might exist and function in different cellular contexts. Clearly, gaining further insight into the dynamics of Dax-1 dimerization and identifying relevant partners of Dax-1 will help translate this unusual structure into physiology.
In summary, we describe the first three-dimensional structure of Dax-1 in association with one of its physiological targets, the nuclear receptor LRH-1. The RH in the Dax-1 LBD, which includes a subfamily conserved sequence motif, 275-PCFXXLP-281, mediates this association. Our findings demonstrate that Dax-1 functions as a ligand-independent nuclear receptor and explain its function as a competitive transcriptional corepressor. The three-dimensional structure of Dax-1 also rationalizes the naturally occurring missense mutations in the human Dax-1 leading to congenital X-linked adrenal hypoplasia. This work should aid in the design of further experiments aimed at clarifying the function of Dax-1 as a potent transcriptional regulator.
Materials and Methods
GST Pull-Down Assay. The GST and the GST protein fusions with LRH-1 and SF-1 LBDs were expressed in Escherichia coli and immobilized on glutathioneagarose beads (Sigma). 35 S-radiolabelled full-length mDax-1 was prepared in vitro in a reticulocyte lysate using the TNT T7 quick-coupled transcriptiontranslation system (Promega) according to the manufacturer's protocol. The immobilized GST proteins with specifically bound mDax-1 were eluted, resolved by SDS-PAGE, and visualized by autoradiography. These experiments showed that only the Dax-1 LBD forms a stable complex with LRH-1. After the LRH-1 His 6 -tag was cleaved by TEV protease, the complex was purified using size-exclusion chromatography (Superdex 75, Amersham Pharmacia). The Dax-1:LRH-1 complex was crystallized by the vapor diffusion method, using a reservoir solution containing 0.1 M Hepes (pH 7.5), 20% PEG 8000, and 1 mM Deoxy-BigChap. Before data collection, crystals were flashfrozen in liquid nitrogen. X-ray diffraction data were obtained at Ϫ180°C to 3.0 Å at the Advanced Light Source beamline 8.3.1 ( ϭ 1.1 Å) using a single crystal. Data were integrated and scaled using DENZO and SCALEPACK. The crystal was of the space group P4 3 with cell dimensions of a ϭ b ϭ 103.4 Å and c ϭ 117.5 Å, and it contained one (Dax-1) 2:LRH-1 heterotrimer in the asymmetric unit. The structure of the complex was determined by the molecular replacement method using the CNS algorithms with a starting model derived from the atomic coordinates for mLRH-1 (PDB ID 1PK5). Electron-density maps based on coefficients 2F o Ϫ Fc were calculated from the phases of the initial model. Subsequent rounds of model building and refinement were performed using the QUANTA and CNS programs, respectively. At later stages of refinement, the structure was checked using simulated annealing composite omit maps.
Preparation
Preparation of His 6-and S-Tagged Dax-1 Fragments for Western Blot Analysis.
Three DNA fragments encoding mDax-1 residues 245-472, 205-472, and 138 -472 with either N-terminal His 6 tags or C-terminal S tags were cloned into pETDuet-1 and pACYCDuet-1 vectors, respectively (Novagen). For coexpression of the His 6-and S-tagged fragments, BL21(DE3)Star cells (Invitrogen) were cotransformed with the corresponding plasmids. Coexpression was induced with 0.1 mM IPTG, and cells were grown for 12 h at 15°C. Cell lysates were loaded onto Ni-NTA matrix, and specifically bound proteins were eluted with 200 mM imidazole. The proteins were resolved by SDS-PAGE and analyzed by Western blot, using mouse anti-S-tag monoclonal antibody and goat anti-mouse IgG alkaline phosphatase conjugate (Novagen), and then developed with colorimetric detection reagents.
Surface Plasmon Resonance (SPR) Assay. The His 6-tagged mLRH-1 LBD and Dax-1 fragments 205-472 and 245-472 were expressed and purified using affinity and size-exclusion chromatography, and the purified LRH-1 LBD was immobilized to an Ni 2ϩ -tri-NTA chip (52) . For SPR assays using anti-GST chips, a DNA fragment encoding mLRH-1 LBD was cloned into a pGEX-4T-1 vector (Amersham Pharmacia). The GST-LRH-1 protein was purified using glutathione sepharose beads and size-exclusion chromatography and immobilized to an anti-GST chip, which was prepared by immobilizing goat anti-GST antibody to a CM5 chip. All measurements were performed using a Biacore T100 instrument. The purified LRH-1 proteins were immobilized to a surface density of about 200 resonance units, and the purified Dax-1 fragments were injected over immobilized LRH-1 and reference surfaces. The equilibrium dissociation constants (K d) were determined using nonlinear regression analysis for the association and dissociation phases of the sensorgrams.
Plasmids, Site-Directed PCR Mutagenesis, and Transfection. The Aro-Luc reporter vector pGL2 was purchased from Promega; pcDNA3, pcDNA3-FLAGmDax-1, and pSG5-SRC-1, pcineo-HAmLRH-1 plasmids were described earlier. Mutagenesis of all LRH-1 and Dax-1 constructs was performed using the QuikChange site-directed mutagenesis kit (Stratagene) according to the manufacturer's protocol. Before the transcriptional assays, expression of all mutant proteins was tested in Cos7 cells by Western blot analysis of nuclear and cytoplasmic extracts using the corresponding antibodies to epitope tags.
